NYSE:USPHU.S. Physical Therapy Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding U.S. Physical Therapy, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $75.70 +0.82 (+1.10 %) (As of 06/2/2020 04:00 PM ET) Add Compare Share Today's Range$73.87Now: $75.70▼$76.0750-Day Range$66.46MA: $71.14▼$77.7452-Week Range$45.13Now: $75.70▼$148.48Volume4,371 shsAverage Volume130,726 shsMarket Capitalization$971.99 millionP/E Ratio33.50Dividend Yield1.73%Beta1.25 ProfileAnalyst RatingsAdvanced ChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company provides industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors As of March 14, 2019, it operated 592 outpatient physical therapy clinics in 42 states; and managed 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The company was founded in 1990 and is based in Houston, Texas.Read More Beat the Market (BTM) Rank™ 3.2 Analyst's Opinion Consensus RatingU.S. Physical Therapy has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $100.00, U.S. Physical Therapy has a potential upside of 32.1% from its current price of $75.70.Amount of Analyst CoverageU.S. Physical Therapy has only been the subject of 2 research reports in the past 90 days. Previous Next 2.0 Community Rank Outperform VotesU.S. Physical Therapy has received 220 “outperform” votes. (Add your “outperform” vote.)Underperform VotesU.S. Physical Therapy has received 317 “underperform” votes. (Add your “underperform” vote.)Community SentimentU.S. Physical Therapy has received 59.03% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about U.S. Physical Therapy and other stocks. Vote “Outperform” if you believe USPH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe USPH will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 4.2 Dividend Strength Dividend LeadershipU.S. Physical Therapy is a leading dividend payer. It pays a dividend yield of 1.73%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthU.S. Physical Therapy has been increasing its dividend for 9 years.Dividend CoverageThe dividend payout ratio of U.S. Physical Therapy is 45.39 %. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, U.S. Physical Therapy will have a dividend payout ratio of 53.33 % next year. This indicates that U.S. Physical Therapy will be able to sustain or increase its dividend. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, U.S. Physical Therapy insiders have sold just slightly more of their company's stock than they have bought. Specifically, they have bought $137,540.00 in company stock and sold $141,821.00 in company stock. It is common for insiders to sell company stock at intervals simply to diversify their holdings.Percentage Held by InsidersOnly 2.50% of the stock of U.S. Physical Therapy is held by insiders. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for U.S. Physical Therapy are expected to grow by 328.57% in the coming year, from $0.56 to $2.40 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of U.S. Physical Therapy is 33.50, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 15.74.Price to Earnings Ratio vs. SectorThe P/E ratio of U.S. Physical Therapy is 33.50, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 25.37.Price to Earnings Growth RatioU.S. Physical Therapy has a PEG Ratio of 10.97. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioU.S. Physical Therapy has a P/B Ratio of 4.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.2Community Rank: 2.0Dividend Strength: 4.2Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -Overall Beat the Market Rank™2.44 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Health services Sub-IndustryHealth Care Facilities SectorMedical Current SymbolNYSE:USPH Previous Symbol CUSIP90337L10 CIK885978 Webwww.usph.com Phone713-297-7000Debt Debt-to-Equity Ratio0.75 Current Ratio2.09 Quick Ratio2.09Price-To-Earnings Trailing P/E Ratio33.50 Forward P/E Ratio135.18 P/E Growth10.97 Sales & Book Value Annual Sales$481.97 million Price / Sales2.02 Cash Flow$3.68 per share Price / Cash Flow20.56 Book Value$18.92 per share Price / Book4.00Profitability EPS (Most Recent Fiscal Year)$2.82 Net Income$40.04 million Net Margins6.17% Return on Equity13.48% Return on Assets5.52%Miscellaneous Employees5,400 Outstanding Shares12,840,000Market Cap$971.99 million Next Earnings Date8/13/2020 (Estimated) OptionableOptionable USPH Rates by TradingView Receive USPH News and Ratings via Email Sign-up to receive the latest news and ratings for USPH and its competitors with MarketBeat's FREE daily newsletter. U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions How has U.S. Physical Therapy's stock been impacted by COVID-19 (Coronavirus)? U.S. Physical Therapy's stock was trading at $93.22 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, USPH stock has decreased by 18.8% and is now trading at $75.70. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of U.S. Physical Therapy? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for U.S. Physical Therapy. When is U.S. Physical Therapy's next earnings date? U.S. Physical Therapy is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for U.S. Physical Therapy. How were U.S. Physical Therapy's earnings last quarter? U.S. Physical Therapy, Inc. (NYSE:USPH) released its quarterly earnings results on Thursday, May, 21st. The company reported $0.30 earnings per share for the quarter, missing analysts' consensus estimates of $0.37 by $0.07. The company earned $112.70 million during the quarter, compared to analysts' expectations of $101.89 million. U.S. Physical Therapy had a net margin of 6.17% and a return on equity of 13.48%. The company's revenue for the quarter was down 3.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.66 EPS. View U.S. Physical Therapy's earnings history. How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy? U.S. Physical Therapy announced a quarterly dividend on Friday, February 28th. Investors of record on Friday, March 13th will be given a dividend of $0.32 per share on Friday, April 17th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 1.69%. The ex-dividend date of this dividend is Thursday, March 12th. This is a positive change from U.S. Physical Therapy's previous quarterly dividend of $0.30. View U.S. Physical Therapy's dividend history. What price target have analysts set for USPH? 3 brokers have issued 1 year target prices for U.S. Physical Therapy's shares. Their forecasts range from $80.00 to $120.00. On average, they expect U.S. Physical Therapy's share price to reach $100.00 in the next year. This suggests a possible upside of 32.1% from the stock's current price. View analysts' price targets for U.S. Physical Therapy. Has U.S. Physical Therapy been receiving favorable news coverage? Media stories about USPH stock have trended positive recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. U.S. Physical Therapy earned a news sentiment score of 2.6 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutU.S. Physical Therapy. Are investors shorting U.S. Physical Therapy? U.S. Physical Therapy saw a increase in short interest in May. As of May 15th, there was short interest totaling 1,110,000 shares, an increase of 7.8% from the April 30th total of 1,030,000 shares. Based on an average daily trading volume, of 165,300 shares, the days-to-cover ratio is currently 6.7 days. Approximately 8.8% of the shares of the stock are short sold. View U.S. Physical Therapy's Current Options Chain. Who are some of U.S. Physical Therapy's key competitors? Some companies that are related to U.S. Physical Therapy include HCA Healthcare (HCA), Universal Health Services (UHS), Acadia Healthcare (ACHC), The Ensign Group (ENSG), Tenet Healthcare (THC), Select Medical (SEM), National HealthCare (NHC), Hanger (HNGR), Brookdale Senior Living (BKD), Community Health Systems (CYH), Five Star Senior Living (FVE), Capital Senior Living (CSU) and Encompass Health (EHC). View all competitors. What other stocks do shareholders of U.S. Physical Therapy own? Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), Marathon Petroleum (MPC), Royal Caribbean Cruises (RCL), Starbucks (SBUX), AbbVie (ABBV), Carnival (CCL), Gilead Sciences (GILD), IBM (IBM), Lowe's Companies (LOW) and AT&T (T). Who are U.S. Physical Therapy's key executives? U.S. Physical Therapy's management team includes the following people: Mr. Christopher J. Reading, Pres, CEO & Director (Age 55)Mr. Lawrance W. McAfee, Exec. VP, CFO & Director (Age 64)Mr. Glenn D. McDowell, Chief Operating Officer of West (Age 62)Mr. Graham Reeve M.B.A., P.T., Chief Operating Officer of East (Age 55)Mr. Jon C. Bates, VP & Corp. Controller What is U.S. Physical Therapy's stock symbol? U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH." Who are U.S. Physical Therapy's major shareholders? U.S. Physical Therapy's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (17.26%), Fred Alger Management LLC (4.10%), State Street Corp (3.39%), Riverbridge Partners LLC (2.90%), Copeland Capital Management LLC (2.31%) and Wasatch Advisors Inc. (2.26%). Company insiders that own U.S. Physical Therapy stock include Christopher J Reading, Clayton Trier, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Jerald L Pullins, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson. View institutional ownership trends for U.S. Physical Therapy. Which major investors are selling U.S. Physical Therapy stock? USPH stock was sold by a variety of institutional investors in the last quarter, including Blair William & Co. IL, Invesco Ltd., First Trust Advisors LP, WINTON GROUP Ltd, UBS Group AG, Schroder Investment Management Group, KBC Group NV, and Russell Investments Group Ltd.. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Christopher J Reading, Clayton Trier, Glenn Mcdowell, Graham D Reeve, Lawrance W Mcafee, and Mark J Brookner. View insider buying and selling activity for U.S. Physical Therapy. Which major investors are buying U.S. Physical Therapy stock? USPH stock was purchased by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., Fred Alger Management LLC, Copeland Capital Management LLC, Morgan Stanley, Morgan Stanley, Bahl & Gaynor Inc., JPMorgan Chase & Co., and BlackRock Inc.. Company insiders that have bought U.S. Physical Therapy stock in the last two years include Harry S Chapman, Kathleen A Gilmartin, and Regg E Swanson. View insider buying and selling activity for U.S. Physical Therapy. How do I buy shares of U.S. Physical Therapy? Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is U.S. Physical Therapy's stock price today? One share of USPH stock can currently be purchased for approximately $75.70. How big of a company is U.S. Physical Therapy? U.S. Physical Therapy has a market capitalization of $971.99 million and generates $481.97 million in revenue each year. The company earns $40.04 million in net income (profit) each year or $2.82 on an earnings per share basis. U.S. Physical Therapy employs 5,400 workers across the globe. What is U.S. Physical Therapy's official website? The official website for U.S. Physical Therapy is www.usph.com. How can I contact U.S. Physical Therapy? U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at 713-297-7000 or via email at [email protected] This page was last updated on 6/2/2020 by MarketBeat.com Staff
